Pursuant to 35 U.S.C. §287(a), Cardiologs Technologies products are protected by one or more U.S. patents. Each product also may be covered by one or more foreign patents and additional patent application(s) may still be pending.
The following list of products and U.S. patents may not be all inclusive, and other products not listed here may be protected by one or more patents.
|Cardiologs ECG Analysis Platform||US10426364, US10758139, US10779744, US10959660|
|Cardiologs ECG Analysis Platform||EP Patent No. 3367897 (AT, BE, CH, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LT, LU, LV, NL, NO, PL, PT, RO, SE, TR)|
PARIS and BOSTON, Feb. 10, 2021 /PRNewswire/ — Cardiologs, a global leader in artificial intelligence (AI) cardiology diagnostics, today announced that results of a clinical study the company conducted in collaboration with Valley Health System…READ FULL
PARIS and BOSTON, Oct. 7, 2020 /PRNewswire/ — Cardiologs, a global leader in artificial intelligence (AI) for cardiac diagnostics, announced today that it has appointed two veteran medical device industry executives to the company’s board…READ FULL
The ECG Holter agreement marks the launch of Cardiologs’ AI-based cloud technology business operations in Europe to detect cardiac rhythm disorders. BOSTON, Sept. 1, 2020 /PRNewswire/ — Cardiologs, a global…READ FULL
Data presented at HRS 2020 shows Cardiologs’ AI-system successfully eliminates more than two-thirds of atrial fibrillation false positives from ILR reports, alleviating the clinical burden associated with remote monitoring PARIS…READ FULL
Trial will evaluate use of Cardiologs’ AI platform for QT interval analysis of ECG data from smartwatches in patients receiving hydroxychloroquine treatment BOSTON, April 22, 2020 /PRNewswire/ — Cardiologs, a…READ FULL
Funding will accelerate adoption of the company’s breakthrough AI-based heart disease diagnostic solution by supporting physicians with unprecedented EKG data analysis and reporting capabilities PARIS and BOSTON, Jan. 10, 2020 /PRNewswire/ — Cardiologs, a global leader…READ FULL